Prochymal
Prochymal
Prochymal (/proʊˈkaɪməl/) is a stem cell therapy product developed by Osiris Therapeutics, an American company. It is used for the treatment of various diseases including Graft-versus-host disease (GVHD) and Crohn's disease.
Etymology
The term "Prochymal" is a proprietary name and does not have a known etymology.
Usage
Prochymal is used in the treatment of acute GVHD in children. It is also being studied for its potential use in other conditions such as Crohn's disease and heart attacks. The therapy involves the intravenous infusion of mesenchymal stem cells derived from the bone marrow of healthy adult donors.
Related Terms
- Stem cell therapy: A treatment that uses stem cells to replace damaged or diseased cells in the body.
- Osiris Therapeutics: A company that develops and markets stem cell products.
- Graft-versus-host disease (GVHD): A medical complication following the receipt of transplanted tissue from a genetically different person.
- Crohn's disease: A type of inflammatory bowel disease that may affect any part of the gastrointestinal tract from mouth to anus.
See Also
External links
- Medical encyclopedia article on Prochymal
- Wikipedia's article - Prochymal
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski